Diagnosing premotor Parkinson's disease using a two-step approach combining olfactory testing and DAT SPECT imaging (Q34020893)

30 July 2017

Diagnosing premotor Parkinson's disease using a two-step approach combining olfactory testing and DAT SPECT imaging (English)

1 reference

30 July 2017

1 reference

1

Henk W Berendse

1 reference

30 July 2017

Mirthe M Ponsen

2

1 reference

30 July 2017

1 December 2009

1 reference

Parkinsonism and Related Disorders

30 July 2017

1 reference

30 July 2017

15 Suppl 3

1 reference

30 July 2017

S26-30

1 reference

Staging of brain pathology related to sporadic Parkinson's disease

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

Non-motor symptoms of Parkinson's disease: diagnosis and management

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

Molecular Pathways of Neurodegeneration in Parkinson's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

alpha-Synuclein: a therapeutic target for Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

Ageing and Parkinson's disease: substantia nigra regional selectivity

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

[123I]beta-CIT SPECT imaging assessment of the rate of Parkinson's disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

[123I] beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

Regional changes in [18F]dopa metabolism in the striatum in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

Striatal dopamine transporter binding assessed by [I-123]IPT and single photon emission computed tomography in patients with early Parkinson's disease: implications for a preclinical diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

Parkinson's disease in twins studied with 18F-dopa and positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

Discordant twins with Parkinson's disease: positron emission tomography and early signs of impaired cognitive circuits

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

Dopaminergic function in familial Parkinson's disease: A clinical and18F-dopa positron emission tomography study

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

The role of inheritance in sporadic Parkinson's disease: evidence from a longitudinal study of dopaminergic function in twins.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

The predictive value of transcranial duplex sonography for the clinical diagnosis in undiagnosed parkinsonian syndromes: comparison with SPECT scans

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

Parkinson's disease: a novel MRI method for determining structural changes in the substantia nigra

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

A comparison of (18)F-dopa PET and inversion recovery MRI in the diagnosis of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

Preclinical Parkinson's disease: detection of motor and nonmotor manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

When did Ray Kennedy's Parkinson's disease begin?

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

Early detection of probable idiopathic Parkinson's disease: I. Development of a diagnostic test battery.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

Bimanual coordination dysfunction in early, untreated Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

Impairment of complex upper limb motor function in de novo Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

Symptoms of autonomic failure in Parkinson's disease: prevalence and impact on daily life

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

The spectrum of neuropsychiatric symptoms in patients with early untreated Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

Cognitive profile of patients with newly diagnosed Parkinson disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

Occurrence and clinical correlates of REM sleep behaviour disorder in patients with Parkinson's disease over time

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

Where does parkinson disease pathology begin in the brain?

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

Olfactory deficits in mice overexpressing human wildtype alpha-synuclein

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

Olfactory function in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

Olfactory impairment in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

Olfactory threshold in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

Olfactory dysfunction in parkinsonism: A general deficit unrelated to neurologic signs, disease stage, or disease duration

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

Olfactory dysfunction in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

Loss of olfaction in de novo and treated Parkinson's disease: possible implications for early diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

A comparative study of odor identification and odor discrimination deficits in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

Prevalence of smell loss in Parkinson's disease--a multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

Extended testing across, not within, tasks raises diagnostic accuracy of smell testing in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

Olfactory testing differentiates between progressive supranuclear palsy and idiopathic Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

Olfactory function in atypical parkinsonian syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

Olfactory function distinguishes vascular parkinsonism from Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

Olfaction differentiates parkin disease from early-onset parkinsonism and Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

Hyposmia in G2019S LRRK2-related parkinsonism: clinical and pathologic data.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

The anterior olfactory nucleus in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

Voxel-wise analysis of diffusion weighted imaging reveals disruption of the olfactory tract in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

Functional imaging of the cerebral olfactory system in patients with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

Advanced time-series analysis of MEG data as a method to explore olfactory function in healthy controls and Parkinson's disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

Olfactory dysfunction in familial parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

Abnormal performance on the PD test battery by asymptomatic first-degree relatives.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

Idiopathic hyposmia as a preclinical sign of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

Olfactory loss may be a first sign of idiopathic Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

Olfactory testing combined with dopamine transporter imaging as a method to detect prodromal Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

Hyposmia and executive dysfunction as predictors of future Parkinson's disease: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

Association of olfactory dysfunction with risk for future Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

Neuropsychological abnormalities in first degree relatives of patients with familial Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

Cognitive deficits precede motor deficits in a slowly progressing model of parkinsonism in the monkey.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

Early detection of probable idiopathic Parkinson's disease: II. A prospective application of a diagnostic test battery

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

Increased cortico-cortical functional connectivity in early-stage Parkinson's disease: An MEG study

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970774-6

7 January 2021

10.1016/S1353-8020(09)70774-6

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

20083001